Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « tcz »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
tcwp < tcz < tdm  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]
Ident.Authors (with country if any)Title
000051 (2020) Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000052 (2020) Yasuhiko Hirabayashi [Japon]Tocilizumab, an anti-interleukin-6 receptor antibody, efficiently ameliorates persistent joint inflammation in rheumatoid arthritis.
000054 (2020) Rongda Li [République populaire de Chine] ; Qi Wan [République populaire de Chine] ; Pan Chen [République populaire de Chine] ; Shufen Mao [République populaire de Chine] ; Qiuju Wang [République populaire de Chine] ; Xiaoxin Li [République populaire de Chine] ; Yi Yang [République populaire de Chine] ; Li Dong [République populaire de Chine]Tocilizumab treatment in Felty's syndrome.
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000057 (2020) Lili Pan [République populaire de Chine] ; Juan Du [République populaire de Chine] ; Jiayi Liu [République populaire de Chine] ; Hua Liao [République populaire de Chine] ; Xiaoli Liu [République populaire de Chine] ; Xi Guo [République populaire de Chine] ; Jing Liang [République populaire de Chine] ; Hongya Han [République populaire de Chine] ; Lixia Yang [République populaire de Chine] ; Yujie Zhou [République populaire de Chine]Tocilizumab treatment effectively improves coronary artery involvement in patients with Takayasu arteritis.
000058 (2020) Masaki Shimizu [Japon] ; Mao Mizuta [Japon] ; Nami Okamoto [Japon] ; Takahiro Yasumi [Japon] ; Naomi Iwata [Japon] ; Hiroaki Umebayashi [Japon] ; Yuka Okura [Japon] ; Noriko Kinjo [Japon] ; Tomohiro Kubota [Japon] ; Yasuo Nakagishi [Japon] ; Kenichi Nishimura [Japon] ; Mariko Mohri [Japon] ; Masato Yashiro [Japon] ; Junko Yasumura [Japon] ; Hiroyuki Wakiguchi [Japon] ; Masaaki Mori [Japon]Tocilizumab modifies clinical and laboratory features of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis
000064 (2020) Juan Ceballos-Macías José [Oman] ; Raúl Rivera-Moscoso ; Alberto Flores-Real Jorge ; Joel Vargas-Sánchez ; Guillermo Ortega-Gutiérrez ; Ram N Madriz-Prado ; Pablo De La Cruz Velasco-Ramos ; Eloy Mu Oz-Monroy Omar ; Carolina Meneses-Pérez Anna ; Nancy Fernández-Morales Irma ; Alfredo Hernández-MorenoTocilizumab in glucocorticoid-resistant graves orbitopathy. A case series report of a mexican population.
000070 (2020) Yasmine F. Ibrahim [Égypte] ; Rabab A. Moussa [Égypte] ; Asmaa M A. Bayoumi [Égypte] ; Al-Shaimaa F. Ahmed [Égypte]Tocilizumab attenuates acute lung and kidney injuries and improves survival in a rat model of sepsis via down-regulation of NF-κB/JNK: a possible role of P-glycoprotein.
000139 (2020) Chayma Ladhari [France] ; Pierre Le Blay [France] ; Thierry Vincent [France] ; Ahmed Larbi [France] ; Emma Rubenstein [France] ; Rosanna Ferreira Lopez [France] ; Christian Jorgensen [France] ; Yves-Marie Pers [France]Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
000143 (2020) Eduardo Mysler [Argentine] ; Mario H. Cardiel [Mexique] ; Ricardo M. Xavier [Brésil] ; Alejandra L Pez ; Allan Ramos-Esquivel [Costa Rica]Subcutaneous Tocilizumab in Monotherapy or in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Latin American Patients With Moderate to Severe Active Rheumatoid Arthritis: A Multicenter, Phase IIIb Study.
000155 (2020) Meng Xu ; Congcong Liu ; Lishuang Guo ; Sirui YangSevere sepsis caused by serious gastrointestinal infection in sJIA patients treated with IL-6 receptor antagonist: a case report
000163 (2020) Jacques Morel [France] ; Marie Locci [France] ; Frédéric Banal [France] ; Bernard Combe [France] ; Grégoire Cormier [France] ; Maxime Dougados [France] ; René-Marc Flipo [France] ; Christian Marcelli [France] ; Thao Pham [France] ; Stéphanie Rist [France] ; Elizabeth Solau Gervais [France] ; Jean Sibilia [France] ; Cédric Lukas [France]Safety of surgery in patients with rheumatoid arthritis treated with tocilizumab: data from the French (REGistry -RoAcTEmra) Regate registry.
000220 (2020) Jamie E. Collins ; Fredrik D. Johansson ; Sara Gale ; Seoyoung Kim ; Swastina Shrestha ; David Sontag ; Jacklyn Stratton ; Huong Trinh ; Chang Xu ; Elena Losina ; Daniel H. SolomonPredicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
000278 (2020) Dimitrios A. Pappas [États-Unis] ; Taylor Blachley [États-Unis] ; Steve Zlotnick [États-Unis] ; Jennie Best [États-Unis] ; Kelechi Emeanuru [États-Unis] ; Joel M. Kremer [États-Unis]Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry.
000295 (2020) Charles Peterfy [États-Unis] ; Joel Kremer [États-Unis] ; William Rigby [États-Unis] ; Nora Singer [États-Unis] ; Christine Birchwood [États-Unis] ; Darcy Gill [États-Unis] ; William Reiss [États-Unis] ; Jinglan Pei [États-Unis] ; Margaret Michalska [États-Unis]Magnetic Resonance Imaging (MRI) Results Following Discontinuation of Methotrexate in Rheumatoid Arthritis Treated with Subcutaneous Tocilizumab: The COMP-ACT MRI Substudy.
000310 (2020) Guoqiang Zhang [République populaire de Chine] ; Hayato Iwase [États-Unis] ; Liaoran Wang [États-Unis] ; Takayuki Yamamoto [États-Unis] ; Abhijit Jagdale [États-Unis] ; David Ayares [États-Unis] ; Yong Li [République populaire de Chine] ; David K C. Cooper [États-Unis] ; Hidetaka Hara [États-Unis]Is interleukin-6 receptor blockade (tocilizumab) beneficial or detrimental to pig-to-baboon organ xenotransplantation?
000340 (2020) Bong-Ha Shin [États-Unis] ; Matthew J. Everly [États-Unis] ; Hao Zhang [États-Unis] ; J. Choi [États-Unis] ; Ashley Vo [États-Unis] ; Xiaohai Zhang [États-Unis] ; Edmund Huang [États-Unis] ; Stanley C. Jordan [États-Unis] ; Mieko Toyoda [États-Unis]Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients With Chronic Antibody-mediated Rejection.
000403 (2020) Hiroki Hoshino [Japon] ; Yoko Shirai [Japon] ; Hiroe Konishi [Japon] ; Takashi Yamamura [Japon] ; Norikazu Shimizu [Japon]Efficacy of tocilizumab for fulminant multiple sclerosis with a tumefactive cervical lesion: A 12-year-old boy.
000413 (2020) Mauricio Cordero-Alfaro [Costa Rica] ; Carlos Le N-Céspedes [Costa Rica] ; Allan Ramos-Esquivel [Costa Rica]Effectiveness of intravenous tocilizumab in routine clinical practice in a cohort of Costa Rican patients with rheumatoid arthritis.
000416 (2020) Dimitrios A. Pappas [États-Unis] ; Carol J. Etzel [États-Unis] ; Margaux Crabtree [États-Unis] ; Taylor Blachley [États-Unis] ; Jennie Best [États-Unis] ; Steve Zlotnick [États-Unis] ; Joel M. Kremer [États-Unis]Effectiveness of Tocilizumab in Patients With Rheumatoid Arthritis is Unaffected by Comorbidity Burden or Obesity: Data From a US Registry.
000430 (2020) Marco A. Cimmino [Italie] ; Massimiliano Parodi [Italie] ; Francesca Barbieri [Italie] ; Stefano Bombardieri [Italie] ; Giuseppe Zampogna [Italie] ; Annamaria Iagnocco [Italie] ; Alberto Batticciotto [Italie] ; Luca Maria Sconfienza [Italie] ; Luigi Sinigaglia [Italie] ; Fabrizio De Benedetti [Italie] ; Fabiola Atzeni [Italie] ; Piercarlo Sarzi-Puttini [Italie]Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "tcz" 
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "tcz" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    tcz
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021